Insider · CIK 0001674797
Evgeny Zaytsev
Files at CALC (CalciMedica, Inc.). First filing -, latest -.
Evgeny Zaytsev files SEC Form 4 as director at CALC (CalciMedica, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Evgeny Zaytsev has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | 8 d ago |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Warrantderivativeindirect: By Bering Partners II, L.P. | +1,450,267 | $0.00 | $0 | 1,450,267 | Aug 21, 2026 |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Warrantderivativeindirect: By Bering Partners II, L.P. | +1,450,267 | $0.00 | $0 | 1,450,267 | Aug 21, 2026 |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 21, 2026 |
| Jul 2, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jul 7, 2026 |
Questions about Evgeny Zaytsev
Answered from the filings on this page, as of the latest one.
Is Evgeny Zaytsev buying or selling?
Evgeny Zaytsev has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Evgeny Zaytsev's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Evgeny Zaytsev has 0.
Where does Evgeny Zaytsev file Form 4?
Evgeny Zaytsev has filed Form 4 at CALC (CalciMedica, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.